Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;60(6):867-73.
doi: 10.1016/j.metabol.2010.08.006. Epub 2010 Oct 12.

Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization

Affiliations

Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization

Paulette M Johnson et al. Metabolism. 2011 Jun.

Abstract

An adaptation to continuous total parenteral nutrition (TPN; 75% of nonprotein calories as glucose) is the liver becomes a major consumer of glucose with lactate release as a by-product. The liver is able to further increase liver glucose uptake when a small dose of fructose is acutely infused via the portal system. Glucagon, commonly elevated during inflammatory stress, is a potent inhibitor of glucose uptake by the liver during TPN. The aim was to determine if continuous fructose infusion could overcome the glucagon-mediated decrease in hepatic glucose uptake. Studies were performed in conscious, insulin-treated, chronically catheterized, pancreatectomized dogs that adapted to TPN for 33 hours. They were then assigned to 1 of 4 groups: TPN (C), TPN + fructose (4.4 μmol kg(-1) min(-1); F), TPN + glucagon (0.2 pmol kg(-1) min(-1); GGN), or TPN + fructose and glucagon (F + GGN) for an additional 63 hours (33-96 hours). Insulin, fructose, and glucagon were infused into the portal vein. During that period, all animals received a fixed insulin infusion of 0.4 mU·kg(-1)·min(-1) (33-96 hours); and the glucose infusion rates were adjusted to maintain euglycemia (6.6 mmol/L). Continuous fructose infusion was unable to further enhance net hepatic glucose uptake (in micromoles per kilogram per minute) (31.1 ± 2.8 vs 36.1 ± 5.0; C vs F), nor was it able to overcome glucagon-mediated decrease in net hepatic glucose uptake (10.0 ± 4.4 vs 12.2 ± 3.9; GGN vs F + GGN). In summary, continuous fructose infusion cannot augment liver glucose uptake during TPN; nor can it overcome the inhibitory effects of glucagon.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement: The authors have no conflicts of interest to disclose

Figures

Figure 1
Figure 1
Arterial plasma glucose concentration, net hepatic glucose uptake and net hepatic glucose fractional extraction in chronically catheterized conscious dogs receiving TPN (C), TPN and fructose (F), TPN and glucagon (GGN), or TPN and both F and GGN (F+GGN). NHGU (F+GGN vs C * p<0.005, F+GGN vs F + p<0.005; G vs C a p<0.005, GGN vs F b p<0.005). Glucose fractional extraction (F+GGN vs C * p<0.005, F+GGN vs F + p<0.005; GGN vs C a p<0.005, GGN vs F b p<0.005) Data are expressed as mean±SEM.

Similar articles

Cited by

References

    1. van den Berghe G, Wilmer A, Hermans G, et al. Intensive Insulin Therapy in the Medical ICU. N Engl J Med. 2006;354:449–461. - PubMed
    1. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367. - PubMed
    1. Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2004;15:45–62. - PubMed
    1. The NICE-SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med. 2009;360:1283–97. - PubMed
    1. Balasubramanyam A. Intensive Glycemic Control in the Intensive Care Unit: Promises and Pitfalls. J Clin Endocrinol Metab. 2009;94:416–417. - PubMed

Publication types

MeSH terms